PubMed:33040469 JSONTXT

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":23,"end":30},"obj":"https://glytoucan.org/Structures/Glycans/G15021LG"},{"id":"T2","span":{"begin":233,"end":240},"obj":"https://glytoucan.org/Structures/Glycans/G15021LG"},{"id":"T3","span":{"begin":532,"end":539},"obj":"https://glytoucan.org/Structures/Glycans/G15021LG"},{"id":"T4","span":{"begin":627,"end":634},"obj":"https://glytoucan.org/Structures/Glycans/G15021LG"},{"id":"T5","span":{"begin":667,"end":674},"obj":"https://glytoucan.org/Structures/Glycans/G15021LG"},{"id":"T6","span":{"begin":810,"end":817},"obj":"https://glytoucan.org/Structures/Glycans/G15021LG"},{"id":"T7","span":{"begin":860,"end":867},"obj":"https://glytoucan.org/Structures/Glycans/G15021LG"}],"text":"Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study.\nHighlights Fasting blood glucose \u003c 10 mmol/L was proposed as a target of glycemic control during the first week of hospitalization in patients with preexisting diabetes. Poor HbA1c levels prior to coronavirus disease 2019 (COVID-19) might not be associated with severity among patients with preexisting diabetes. Mean blood glucose seemed not to be associated with poor prognosis of COVID-19. Dynamics of fasting blood glucose, mean 2-hour postprandial blood glucose of coronavirus disease 2019 (COVID-19) patients with preexisting diabetes. This figure depicts the average values of (A) fasting blood glucose, (B) daily mean 2-hour postprandial blood glucose of COVID-19 patients with preexisting diabetes. Red lines represent the patients with preexisting diabetes who progressed to severe illness during admission (n=23), and blue lines represent those with preexisting diabetes who stayed nonsevere (n=26)."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":17,"end":22},"obj":"Body_part"},{"id":"T2","span":{"begin":23,"end":30},"obj":"Body_part"},{"id":"T3","span":{"begin":227,"end":232},"obj":"Body_part"},{"id":"T4","span":{"begin":233,"end":240},"obj":"Body_part"},{"id":"T5","span":{"begin":526,"end":531},"obj":"Body_part"},{"id":"T6","span":{"begin":532,"end":539},"obj":"Body_part"},{"id":"T7","span":{"begin":621,"end":626},"obj":"Body_part"},{"id":"T8","span":{"begin":627,"end":634},"obj":"Body_part"},{"id":"T9","span":{"begin":661,"end":666},"obj":"Body_part"},{"id":"T10","span":{"begin":667,"end":674},"obj":"Body_part"},{"id":"T11","span":{"begin":804,"end":809},"obj":"Body_part"},{"id":"T12","span":{"begin":810,"end":817},"obj":"Body_part"},{"id":"T13","span":{"begin":854,"end":859},"obj":"Body_part"},{"id":"T14","span":{"begin":860,"end":867},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma82743"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma82743"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma82743"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma82743"},{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma82743"},{"id":"A11","pred":"fma_id","subj":"T11","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma82743"},{"id":"A13","pred":"fma_id","subj":"T13","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A14","pred":"fma_id","subj":"T14","obj":"http://purl.org/sig/ont/fma/fma82743"}],"text":"Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study.\nHighlights Fasting blood glucose \u003c 10 mmol/L was proposed as a target of glycemic control during the first week of hospitalization in patients with preexisting diabetes. Poor HbA1c levels prior to coronavirus disease 2019 (COVID-19) might not be associated with severity among patients with preexisting diabetes. Mean blood glucose seemed not to be associated with poor prognosis of COVID-19. Dynamics of fasting blood glucose, mean 2-hour postprandial blood glucose of coronavirus disease 2019 (COVID-19) patients with preexisting diabetes. This figure depicts the average values of (A) fasting blood glucose, (B) daily mean 2-hour postprandial blood glucose of COVID-19 patients with preexisting diabetes. Red lines represent the patients with preexisting diabetes who progressed to severe illness during admission (n=23), and blue lines represent those with preexisting diabetes who stayed nonsevere (n=26)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":17,"end":22},"obj":"Body_part"},{"id":"T2","span":{"begin":227,"end":232},"obj":"Body_part"},{"id":"T3","span":{"begin":526,"end":531},"obj":"Body_part"},{"id":"T4","span":{"begin":621,"end":626},"obj":"Body_part"},{"id":"T5","span":{"begin":661,"end":666},"obj":"Body_part"},{"id":"T6","span":{"begin":804,"end":809},"obj":"Body_part"},{"id":"T7","span":{"begin":854,"end":859},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study.\nHighlights Fasting blood glucose \u003c 10 mmol/L was proposed as a target of glycemic control during the first week of hospitalization in patients with preexisting diabetes. Poor HbA1c levels prior to coronavirus disease 2019 (COVID-19) might not be associated with severity among patients with preexisting diabetes. Mean blood glucose seemed not to be associated with poor prognosis of COVID-19. Dynamics of fasting blood glucose, mean 2-hour postprandial blood glucose of coronavirus disease 2019 (COVID-19) patients with preexisting diabetes. This figure depicts the average values of (A) fasting blood glucose, (B) daily mean 2-hour postprandial blood glucose of COVID-19 patients with preexisting diabetes. Red lines represent the patients with preexisting diabetes who progressed to severe illness during admission (n=23), and blue lines represent those with preexisting diabetes who stayed nonsevere (n=26)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":125,"end":133},"obj":"Disease"},{"id":"T2","span":{"begin":163,"end":171},"obj":"Disease"},{"id":"T3","span":{"begin":368,"end":376},"obj":"Disease"},{"id":"T4","span":{"begin":405,"end":429},"obj":"Disease"},{"id":"T5","span":{"begin":431,"end":439},"obj":"Disease"},{"id":"T6","span":{"begin":511,"end":519},"obj":"Disease"},{"id":"T7","span":{"begin":591,"end":599},"obj":"Disease"},{"id":"T8","span":{"begin":678,"end":702},"obj":"Disease"},{"id":"T9","span":{"begin":704,"end":712},"obj":"Disease"},{"id":"T10","span":{"begin":740,"end":748},"obj":"Disease"},{"id":"T11","span":{"begin":871,"end":879},"obj":"Disease"},{"id":"T12","span":{"begin":906,"end":914},"obj":"Disease"},{"id":"T13","span":{"begin":966,"end":974},"obj":"Disease"},{"id":"T14","span":{"begin":1081,"end":1089},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"}],"text":"Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study.\nHighlights Fasting blood glucose \u003c 10 mmol/L was proposed as a target of glycemic control during the first week of hospitalization in patients with preexisting diabetes. Poor HbA1c levels prior to coronavirus disease 2019 (COVID-19) might not be associated with severity among patients with preexisting diabetes. Mean blood glucose seemed not to be associated with poor prognosis of COVID-19. Dynamics of fasting blood glucose, mean 2-hour postprandial blood glucose of coronavirus disease 2019 (COVID-19) patients with preexisting diabetes. This figure depicts the average values of (A) fasting blood glucose, (B) daily mean 2-hour postprandial blood glucose of COVID-19 patients with preexisting diabetes. Red lines represent the patients with preexisting diabetes who progressed to severe illness during admission (n=23), and blue lines represent those with preexisting diabetes who stayed nonsevere (n=26)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":17,"end":22},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T2","span":{"begin":17,"end":22},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T3","span":{"begin":173,"end":174},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T4","span":{"begin":227,"end":232},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T5","span":{"begin":227,"end":232},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T6","span":{"begin":269,"end":270},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T7","span":{"begin":526,"end":531},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T8","span":{"begin":526,"end":531},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T9","span":{"begin":621,"end":626},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T10","span":{"begin":621,"end":626},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T11","span":{"begin":661,"end":666},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T12","span":{"begin":661,"end":666},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T13","span":{"begin":793,"end":794},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T14","span":{"begin":804,"end":809},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T15","span":{"begin":804,"end":809},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T16","span":{"begin":820,"end":821},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T17","span":{"begin":854,"end":859},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T18","span":{"begin":854,"end":859},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"}],"text":"Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study.\nHighlights Fasting blood glucose \u003c 10 mmol/L was proposed as a target of glycemic control during the first week of hospitalization in patients with preexisting diabetes. Poor HbA1c levels prior to coronavirus disease 2019 (COVID-19) might not be associated with severity among patients with preexisting diabetes. Mean blood glucose seemed not to be associated with poor prognosis of COVID-19. Dynamics of fasting blood glucose, mean 2-hour postprandial blood glucose of coronavirus disease 2019 (COVID-19) patients with preexisting diabetes. This figure depicts the average values of (A) fasting blood glucose, (B) daily mean 2-hour postprandial blood glucose of COVID-19 patients with preexisting diabetes. Red lines represent the patients with preexisting diabetes who progressed to severe illness during admission (n=23), and blue lines represent those with preexisting diabetes who stayed nonsevere (n=26)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":23,"end":30},"obj":"Chemical"},{"id":"T3","span":{"begin":233,"end":240},"obj":"Chemical"},{"id":"T5","span":{"begin":532,"end":539},"obj":"Chemical"},{"id":"T7","span":{"begin":627,"end":634},"obj":"Chemical"},{"id":"T9","span":{"begin":667,"end":674},"obj":"Chemical"},{"id":"T11","span":{"begin":810,"end":817},"obj":"Chemical"},{"id":"T13","span":{"begin":860,"end":867},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A2","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A4","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A6","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A8","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A10","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"},{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A12","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"},{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A14","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"}],"text":"Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study.\nHighlights Fasting blood glucose \u003c 10 mmol/L was proposed as a target of glycemic control during the first week of hospitalization in patients with preexisting diabetes. Poor HbA1c levels prior to coronavirus disease 2019 (COVID-19) might not be associated with severity among patients with preexisting diabetes. Mean blood glucose seemed not to be associated with poor prognosis of COVID-19. Dynamics of fasting blood glucose, mean 2-hour postprandial blood glucose of coronavirus disease 2019 (COVID-19) patients with preexisting diabetes. This figure depicts the average values of (A) fasting blood glucose, (B) daily mean 2-hour postprandial blood glucose of COVID-19 patients with preexisting diabetes. Red lines represent the patients with preexisting diabetes who progressed to severe illness during admission (n=23), and blue lines represent those with preexisting diabetes who stayed nonsevere (n=26)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"4","span":{"begin":23,"end":30},"obj":"Chemical"},{"id":"5","span":{"begin":125,"end":133},"obj":"Disease"},{"id":"6","span":{"begin":137,"end":145},"obj":"Species"},{"id":"7","span":{"begin":163,"end":171},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"tao:has_database_id","subj":"4","obj":"MESH:D005947"},{"id":"A5","pred":"tao:has_database_id","subj":"5","obj":"MESH:C000657245"},{"id":"A6","pred":"tao:has_database_id","subj":"6","obj":"Tax:9606"},{"id":"A7","pred":"tao:has_database_id","subj":"7","obj":"MESH:D003920"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study.\nHighlights Fasting blood glucose \u003c 10 mmol/L was proposed as a target of glycemic control during the first week of hospitalization in patients with preexisting diabetes. Poor HbA1c levels prior to coronavirus disease 2019 (COVID-19) might not be associated with severity among patients with preexisting diabetes. Mean blood glucose seemed not to be associated with poor prognosis of COVID-19. Dynamics of fasting blood glucose, mean 2-hour postprandial blood glucose of coronavirus disease 2019 (COVID-19) patients with preexisting diabetes. This figure depicts the average values of (A) fasting blood glucose, (B) daily mean 2-hour postprandial blood glucose of COVID-19 patients with preexisting diabetes. Red lines represent the patients with preexisting diabetes who progressed to severe illness during admission (n=23), and blue lines represent those with preexisting diabetes who stayed nonsevere (n=26)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":172},"obj":"Sentence"},{"id":"T2","span":{"begin":173,"end":207},"obj":"Sentence"},{"id":"T3","span":{"begin":208,"end":377},"obj":"Sentence"},{"id":"T4","span":{"begin":378,"end":520},"obj":"Sentence"},{"id":"T5","span":{"begin":521,"end":600},"obj":"Sentence"},{"id":"T6","span":{"begin":601,"end":749},"obj":"Sentence"},{"id":"T7","span":{"begin":750,"end":915},"obj":"Sentence"},{"id":"T8","span":{"begin":916,"end":1118},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study.\nHighlights Fasting blood glucose \u003c 10 mmol/L was proposed as a target of glycemic control during the first week of hospitalization in patients with preexisting diabetes. Poor HbA1c levels prior to coronavirus disease 2019 (COVID-19) might not be associated with severity among patients with preexisting diabetes. Mean blood glucose seemed not to be associated with poor prognosis of COVID-19. Dynamics of fasting blood glucose, mean 2-hour postprandial blood glucose of coronavirus disease 2019 (COVID-19) patients with preexisting diabetes. This figure depicts the average values of (A) fasting blood glucose, (B) daily mean 2-hour postprandial blood glucose of COVID-19 patients with preexisting diabetes. Red lines represent the patients with preexisting diabetes who progressed to severe illness during admission (n=23), and blue lines represent those with preexisting diabetes who stayed nonsevere (n=26)."}